Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kentsch

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Drugs in R&D|November 24, 1999
Novel neurohormonal modulators in cardiovascular disorders. The therapeutic potential of endopeptidase inhibitorsM Kentsch, W Otter
Der Internist|August 1, 1989
[A 65-year-old patient with acromegaly, recent appearance of dyspnea and tibial edema]M Kentsch, G Müller-Esch
Zeitschrift Fur Arztliche Fortbildung|August 1, 1995
[5 years experience with resuscitation courses]M J von Bose, M Kentsch
Der Internist|February 1, 1992
[Intensive care intervention in gestosis]M Haider, M Kentsch, H Schad
Intensive Care Medicine|January 1, 1990
Early prediction of prognosis in out-of-hospital cardiac arrestM Kentsch, M Stendel, H Berkel, et al.
Deutsche Medizinische Wochenschrift (1946)|September 13, 1991
[Urodilatin. The clinical importance of the renal natriuretic peptide]M Kentsch, C Drummer, G Müller-Esch, et al.
European Journal of Clinical Investigation|April 1, 1995
Severe hypotension and bradycardia after continuous intravenous infusion of urodilatin (ANP 95-126) in a patient with congestive heart failureM Kentsch, C Drummer, R Gerzer, et al.
European Journal of Clinical Investigation|October 1, 1992
Haemodynamic and renal effects of urodilatin bolus injections in patients with congestive heart failureM Kentsch, D Ludwig, C Drummer, et al.
Anesthesiology|October 1, 1991
Intravenous dantrolene does not exhibit calcium channel blocking effects on the cardiac conduction system in humansM Kentsch, N Roewer, K P Kunze, et al.
Zeitschrift Fur Kardiologie|September 1, 1988
[Electrophysiologic properties of accessory atrioventricular pathways. Comparison with myocardial tissue and relation to site]M Kentsch, K P Kunze, W Bleifeld, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Drugs in R&D|November 24, 1999
Novel neurohormonal modulators in cardiovascular disorders. The therapeutic potential of endopeptidase inhibitorsM Kentsch, W Otter
Der Internist|August 1, 1989
[A 65-year-old patient with acromegaly, recent appearance of dyspnea and tibial edema]M Kentsch, G Müller-Esch
Zeitschrift Fur Arztliche Fortbildung|August 1, 1995
[5 years experience with resuscitation courses]M J von Bose, M Kentsch
Der Internist|February 1, 1992
[Intensive care intervention in gestosis]M Haider, M Kentsch, H Schad
Intensive Care Medicine|January 1, 1990
Early prediction of prognosis in out-of-hospital cardiac arrestM Kentsch, M Stendel, H Berkel, et al.
Deutsche Medizinische Wochenschrift (1946)|September 13, 1991
[Urodilatin. The clinical importance of the renal natriuretic peptide]M Kentsch, C Drummer, G Müller-Esch, et al.
European Journal of Clinical Investigation|April 1, 1995
Severe hypotension and bradycardia after continuous intravenous infusion of urodilatin (ANP 95-126) in a patient with congestive heart failureM Kentsch, C Drummer, R Gerzer, et al.
European Journal of Clinical Investigation|October 1, 1992
Haemodynamic and renal effects of urodilatin bolus injections in patients with congestive heart failureM Kentsch, D Ludwig, C Drummer, et al.
Anesthesiology|October 1, 1991
Intravenous dantrolene does not exhibit calcium channel blocking effects on the cardiac conduction system in humansM Kentsch, N Roewer, K P Kunze, et al.
Zeitschrift Fur Kardiologie|September 1, 1988
[Electrophysiologic properties of accessory atrioventricular pathways. Comparison with myocardial tissue and relation to site]M Kentsch, K P Kunze, W Bleifeld, et al.
Pageof 3